Background and Purpose An elevated intracellular calcium level is known to be a major initiator and activator of ischemic cell death pathway; however, in recent studies, elevated serum calcium levels have been associated with better clinical outcomes and smaller cerebral infarct volumes. The pathophysiological role played by calcium in ischemic stroke is largely unknown. Methods Acute stroke patients from a prospective stroke registry, consecutively admitted during October 2002-September 2008, were included. Significant associations between the modified Rankin scale distribution at discharge and serum calcium or albumin-corrected calcium were identified using ordinal logistic regression analysis. Cox proportional hazard models were used for survival analysis. Results Mean serum calcium and albumin-corrected calcium levels of the 1,915 participants on admission were 8.97 ± 0.58 mg/dL and 9.07 ± 0.49 mg/dL, respectively. Second [adjusted odds ratio 1.32 (95% confidence interval 1.07-1.61)] and third [1.24 (1.01-1.53)] tertiles of serum calcium level and the third [1.24 (1.01-1.53)] tertile of albumin-corrected calcium level were found to be independent risk factors for a poor discharge outcome. Significant relationships were observed with serum calcium [1.19 (1.03-1.38)] and albumin-corrected calcium [1.21(1.01-1.44)] as linear variables. However, only albumin-corrected calcium was associated with long-term mortality, third tertile [adjusted hazard ratio 1.40 (1.07-1.83)], and increase by 1 mg/dL [1.46 (1.16-1.84)]. Conclusions Elevated albumin-corrected serum calcium levels are associated with a poorer short-term outcome and greater risk of long-term mortality after acute ischemic stroke.
Introduction
The calcium ion (Ca 2+ ) is a ubiquitous intracellular messenger during and immediately after an ischemic period, and it influences the cascade of events that lead to subsequent neuronal injury. 1 Under ischemic conditions, release of glutamate from the neurons and glia activates the N-methyl-D-aspartate (NMDA) receptor and triggers the rapid translocation of Ca 2+ from extracellular to intracellular spaces in cerebral tissues. 2, 3 Experimental results indicate that Ca 2+ can have a harmful effect on neurons under acute ischemic conditions. The harmful effects of Ca 2+ have been studied in regard to its relationship with prevention of neuronal injury in acute ischemia. One small-scale study showed a significant reduction in mortality and neurological impairment after the administration of nimodipine (a calcium antagonist). 4 Furthermore, collective results suggest that early therapy with oral nimodipine favorably influences the course of acute ischemic stroke. 5 In contrast to a previously held belief, 6, 7 recent studies suggest that elevated serum calcium levels within 24 hours of stroke onset are associated with smaller infarction volumes and better clinical outcomes after hospital discharge. 8, 9 Interestingly, Appel et al. reported that serum calcium levels at both extremes are associated with greater mortality, and noted optimal long-term survival for a distinct range of serum calcium levels. 10 In this study, based on the physiologic character of Ca 2+ in ischemic conditions, we hypothesized that elevated levels of serum calcium and albumin-corrected calcium may be associated with a poor outcome after stroke in terms of neurologic severity at discharge and mortality.
Methods

Study population
Acute stroke patients admitted to Seoul National University Hospital between October 2002 and September 2008 within 7 days of symptom onset were identified from a prospective stroke registry database, and analyzed for this study. The information collected from each patient included stroke subtype as classified by the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria, 11 the National Institutes of Health Stroke Scale (NIHSS) score at the time of admission, thrombolytic treatment during the hyperacute period, and the modified Rankin Scale (mRS) score at discharge (the latter was used as a measure of early functional outcome after stroke). The institutional review board approved the study despite the absence of patient consent due to its retrospective nature and minimal risk to participants [IRB No. H-1011-004-337].
Demographic characteristics and laboratory data
Baseline demographic and clinical characteristics of all study participants were collected. This included gender, age, height, body weight, and vascular risk factors such as hypertension (previous use of antihypertensive medication and systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg at discharge), diabetes (previous use of a glucose-lowering medication and fasting blood glucose > 7 mmol/L or postprandial blood glucose after 2 hours > 11.1 mmol/L at discharge), hyperlipidemia (previous use of a lipid-lowering medication and total cholesterol > 6.0 mmol/L or low-density lipoprotein cholesterol > 4.14 mmol/L at discharge), and current smoking. [12] [13] [14] We also collated patient laboratory data, which included serum levels of glucose, hemoglobin A1c, total cholesterol, high-density lipoprotein cholesterol, triglycerides, low-density lipoprotein, albumin, and calcium. Albumin-corrected calcium levels were calculated using the formula: albumin corrected calcium (mg/dL) = serum calcium (mg/dL) + 0.8 [4-serum albumin (g/dL)]. 15 
Mortality information
The vital status of the participants was ascertained using data obtained from Statistics Korea, a governmental statistical office that manages demographic statistics in Korea, which has been used and considered as reliable data in previous studies. 16, 17 
Statistical analysis
Differences between the groups were analyzed using the χ 2 test for categorical variables and the Student t-test or the MannWhitney U test for continuous variables. To test for significant associations between mRS distribution at discharge and serum levels of calcium or albumin-corrected calcium, ordinal logistic regression analyses was used, taking the 6 categorized mRS score (i.e., mRS scores 5 and 6 combined) as a dependent variable under the assumption of proportional odds. In addition, Cox proportional hazard models were constructed to test the effects of serum calcium or albumin-corrected calcium levels on mortality after stroke. For ordinal logistic regression models and Cox proportional hazard models, adjusted variables with P values < 0.05 were selected by univariate analysis. Serum calcium and albumin-corrected calcium levels were entered into multivariable models separately. To detect the threshold effect of calcium or albumin-corrected calcium levels on outcomes in model 1, these two variables were classified by tertiles (T1 < 8.9; T2 8.9-9.2; T3 > 9.2 for calcium and T1 < 8.90; T2 8.90-9.28; T3 > 9.28 for albumin-corrected calcium), and the tertiles were chosen based on sample size. Serum calcium and albumin-corrected calcium levels were analyzed as continuous data in model 2. Significance was set at a two-tailed P level of < 0.05. Values have been presented as frequencies (percentages), means ± standard deviations, or medians [interquartile ranges (IQR)], as appropriate. All statistical analyses were performed using the SPSS 21.0 (IBM Inc., Armonk, NY, USA).
Results
Our acute stroke registry comprised 2,313 patients. However, we excluded patients with history of an intracranial hemorrhage (n= 232), transient ischemic attack (n= 124), and those without information on important clinical variables (n= 15) or functional outcomes (n = 27). As a result, 1,915 stroke patients were enrolled in this study. Of these, 1,184 were men and 731 were women. Patients' age ranged from 16 to 98 years (mean 65.7 ± 12.2 years). The mean serum calcium and albumin-corrected calcium levels on admission were 8.97± 0.58 mg/dL and 9.07± 0.49 mg/ dL respectively, and the median initial NIHSS score was 4 [2, 7 (IQR)]. The mean follow-up period was 917 ± 609 days (range 1-2,248 days). The mortality rate was 1.6% (31 patients) at 1 month post-admission, and the overall mortality rate was 17.3% (332 patients). Patient baseline characteristics by vital status are shown in Table 1 . Table 3 . In terms of mortality, multivariable analysis was performed using Cox proportional hazard regression analysis models ( (Table 5) . However, no significant association was found between serum calcium level and long-term mortality.
Discussion
The present study shows that high levels of albumin-corrected calcium are associated with a poor discharge outcome and a higher incidence of mortality after acute ischemic stroke. This association was found using the highest tertile model and the continuous 1 mg/dL increase model. Furthermore, the association between the discharge outcome and serum calcium level was also found to be significant when we used serum calcium levels in a continuous 1 mg/dL increase model. However, in the tertile model, the middle tertile was found to be more strongly associated with a poor outcome than the highest tertile. With regard to mortality, serum calcium and albumin-corrected calcium showed discrepant results as the association between mortality and albumin-corrected calcium level was identified by the highest tertile model and the continuous 1 mg/dL increase model, but these relations were not found for serum calcium.
The differences in the results obtained for the serum calcium and albumin-corrected calcium levels may be explained by the physiologic characteristics of Ca 2+ . About half of the calcium in the serum is bound to serum proteins, particularly to albumin. Accordingly, changes in protein concentration alone cause changes in total calcium without affecting the physiologically and clinically important ionized calcium, and thus, adjustment of the total serum calcium concentration for albumin is essential when attempting to detect abnormal values. 18 For these reasons, albumincorrected calcium is a better parameter for evaluating the effect of calcium at the cellular level when directly measured ionized calcium concentration is not available.
The underlying biological mechanism responsible for the poor short-term outcome and increased mortality associated with elevated albumin-corrected calcium levels has not been established. Experimental studies have demonstrated that influx of Ca 2+ into neuronal cells is a mechanism of ischemic cell death. Glutamatestimulated Ca 2+ influx into cultured neurons by 45 Ca
2+
, and elevated Ca 2+ levels after NMDA receptor stimulation has been observed repeatedly using fluorescent probes. 19, 20 Furthermore, it has also been shown that inhibition of the effectors of Ca 2+ tox- icity, such as calmodulin, 21 calcineurin, 22 or neuronal nitric oxide synthase, 23 protects neurons against the toxic effects of excitatory amino acids. These studies suggest that elevated extracellular Ca 2+ levels increase the risk of early neuronal death caused by NMDA receptor-mediated Ca 2+ intracellular influx. Mitochondrial dysfunction also contributes to delayed neuronal death, and it was established decades ago that massive calcium accumulation triggers mitochondrial damage. 24 Increases in mitochondrial permeability are caused by the formation of high conductivity proteinaceous pores that allow the passage of ions and molecules. 25, 26 Furthermore, mitochondria exposed to calcium swell and release their contents. 25 In addition, oxidative stress and mitochondrial calcium accumulation activate mitochondrial permeability transition and lead to depolarization-coupled production of reactive oxygen species. 27 This relationship between calcium and mitochondria may explain the association of the calcium level with a poor neurological outcome in stroke.
The results of the present study should be interpreted with some caution. First, our study was conducted in a retrospective manner, and patients without calcium level, height, or admission NIHSS data were excluded from the analysis. However, only 2.12% of all potential participants were excluded, and thus, we believe that the quality of the data was acceptable. Second, we used discharge mRS scores as a measure of short-term neurological outcome, and thus, these scores were allocated at different times after stroke onset; the 3-month follow-up NIHSS and mRS scores were not collected. However, mRS was administered when medically and neurologically stabilized patients were transferred to rehabilitation services or discharged to home, and mRS scores at discharge may better represent the severity of early neurologic involvement compared to the 3-month follow-up scores because of individual differences in medical care. Third, none of the patients in our study had hypercalcemia (calcium level ≥ 12.0 mg/dL). Due to the retrospective nature of our study, we were unable to correct this issue. Fourth, information regarding stroke location, lesion volume, and post-discharge medical care quality, the well-known factors associated with short and long-term clinical outcomes of ischemic stroke patients, was not captured in this study. Fifth, serum albumin level could be an important interacting variable for the relationship between albumin-corrected calcium level and stroke outcome. A thorough statistical analysis for such a relation was not performed in the current study. However, albumin-corrected calcium level was a significant prognostic factor for short-and long-term stroke outcomes, after adjusting for serum albumin level. Finally, the calcium level was checked once on the day of admission, whereas Ovbiagele et al. reported that serum calcium levels obtained within 72-96 hours of stroke onset are of prognostic significance. 28 However, the annual intra-individual calcium level variation is only~2%, and calcium transport from the extracellular area into neuronal cells would not be sufficient to change serum levels to the degree noted in our study. 29 Thus, we argue that the timing of the calcium level measurements is not important in the context of this study.
Conclusion
We found that higher albumin-corrected calcium levels were of prognostic significance in terms of early neurologic outcome and long-term mortality after acute ischemic stroke. Furthermore, albumin-corrected calcium showed a more clear association in our results than serum calcium. Prospective studies with direct measurements of calcium ion concentrations at various times after stroke onset are required to obtain more information regarding the pathophysiologic role of Ca 2+ in ischemic neuronal injury.
